secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001193125-26-213373
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Atossa shareholders approve reverse stock split up to 20:1, re-elect directors
------------------------------------------------------------------------------

- Reverse stock split amendment approved: 2,336,815 for, 1,866,873 against, 33,271 abstentions.
- Three Class II directors re-elected: Galli, Steinhart, Cigler; broker non-votes ~2.2M each.
- Ratification of Ernst & Young as auditor for FY 2026 passed: 3.7M for, 370K against, 151K abstentions.
- Advisory vote on executive compensation approved: 1.53M for, 444K against, 2.22M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000119312526213373/0001193125-26-213373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000119312526213373/atos-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-213373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer